Frances M. Weaver
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Frances M. Weaver has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
Beverly Gonzalez
Cooperative Studies Coordinating Center, Edward Hines Jr. VA Hospital, Hines, IL, USA
6 shared publications- Sherri L. LaVela
Edward Hines Jr. VA Hospital
6 shared publications Lishan Cao
Center of Innovation for Complex Chronic Healthcare (CINCCH), Edward Hines Jr. VA Hospital, Hines, IL, USA
5 shared publicationsBridget Smith
Hines Veterans Affairs Hospital, Center of Innovation for Complex Chronic Healthcare Hines Illinois USA
4 shared publicationsCharlesnika T. Evans
Center of Innovation for Complex Chronic Healthcare, Edward Hines, Jr. VA Hospital Hines Illinois USA
4 shared publicationsDolores Ippolito
Center of Innovation for Complex Chronic Healthcare Hines VA Hospital Hines IL
4 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Springer Nature in Journal of General Internal Medicine
- p. 1-11
Examining Trust Among Veterans from Camp Lejeune Exposed to Environmental Toxicants: A Qualitative Study
Background: Serving Veterans with military environmental exposures is a top priority of the Veterans Health Administration (VHA). This priority is critical for over 1 million Veterans and civilians who were exposed to contaminated drinking water at United States Marine Corps (USMC) Base Camp Lejeune (CL) between 1953 and 1987. Since 2012, VHA has enacted various legislation to provide healthcare coverage and monetary relief for harm caused by water contamination. Objective: To understand the perceived impact of toxicant exposure at CL on Veterans’ trust in the VHA. Design: This is a qualitative study based on semi-structured telephone interviews between February 2024 and May 2024 to understand Veteran experiences with toxicant exposure and feelings of trust. Participants: Twenty-two Veterans who served at CL during the officially recognized contamination period were interviewed (68.2% male; mean age 63 years; 72.7% White). Approach: Recruitment included contacting participants who completed a previous survey and posting an invitation on two private CL Facebook pages. Interviews were audio-recorded and transcribed, then a codebook was developed inductively. During thematic analysis, we synthesized overarching themes, later organized into the Health Systems Trust Content Area Framework. Key Results: We developed three key themes. First, reasons for trust included Veterans’ positive experiences with VHA healthcare. Second, reasons for lack of trust in Veterans Affairs included poor experiences with healthcare, lack of transparency, and complicated claims processes. Third, Veterans’ trust in the VHA was complicated by external factors, including the USMC and US government. Conclusions: These findings suggest that CL Veterans’ trust in the VHA is shaped by complex factors, including potentially modifiable factors (e.g., healthcare access, transparency). Future efforts to measure and rebuild trust in this vulnerable population should include continued collaboration with Veterans, drawing on their specific experiences and lessons from past contaminations, for improved health policy and greater VHA service use.
- 16 September 2026
- Published by Springer Nature in Journal of General Internal Medicine
- p. 1-11
Open AccessExamining Trust Among Veterans from Camp Lejeune Exposed to Environmental Toxicants: A Qualitative Study
Background: Serving Veterans with military environmental exposures is a top priority of the Veterans Health Administration (VHA). This priority is critical for over 1 million Veterans and civilians who were exposed to contaminated drinking water at United States Marine Corps (USMC) Base Camp Lejeune (CL) between 1953 and 1987. Since 2012, VHA has enacted various legislation to provide healthcare coverage and monetary relief for harm caused by water contamination. Objective: To understand the perceived impact of toxicant exposure at CL on Veterans’ trust in the VHA. Design: This is a qualitative study based on semi-structured telephone interviews between February 2024 and May 2024 to understand Veteran experiences with toxicant exposure and feelings of trust. Participants: Twenty-two Veterans who served at CL during the officially recognized contamination period were interviewed (68.2% male; mean age 63 years; 72.7% White). Approach: Recruitment included contacting participants who completed a previous survey and posting an invitation on two private CL Facebook pages. Interviews were audio-recorded and transcribed, then a codebook was developed inductively. During thematic analysis, we synthesized overarching themes, later organized into the Health Systems Trust Content Area Framework. Key Results: We developed three key themes. First, reasons for trust included Veterans’ positive experiences with VHA healthcare. Second, reasons for lack of trust in Veterans Affairs included poor experiences with healthcare, lack of transparency, and complicated claims processes. Third, Veterans’ trust in the VHA was complicated by external factors, including the USMC and US government. Conclusions: These findings suggest that CL Veterans’ trust in the VHA is shaped by complex factors, including potentially modifiable factors (e.g., healthcare access, transparency). Future efforts to measure and rebuild trust in this vulnerable population should include continued collaboration with Veterans, drawing on their specific experiences and lessons from past contaminations, for improved health policy and greater VHA service use.
- Open Access
- 29 June 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e77241
Repetitive Transcranial Magnetic Stimulation as a Cognitive Rehabilitation Approach for Veterans With Parkinson Disease and Mild Cognitive Impairment: Protocol for a Randomized Sham-Controlled Trial
Background: Parkinson disease (PD) is characterized by motor symptoms as well as progressive cognitive decline leading to long-term functional impairment and diminished quality of life. Mild cognitive impairment in PD (PD-MCI) is a risk factor for developing PD-related dementia. PD-MCI provides a window to assess interventions that can improve cognition. Repetitive transcranial magnetic stimulation (rTMS) shows promise as an effective treatment to improve cognitive performance. Objective: This study aims to test the safety and feasibility of a 10-session, high-frequency rTMS protocol applied to the left dorsolateral prefrontal cortex and the rTMS efficacy in improving cognitive test performance among veterans with PD-MCI. Methods: This is a double-blind randomized controlled trial. We will enroll US military veterans with PD-MCI. Participants will be randomized to either active or sham rTMS treatment groups, each with 10 treatment sessions (2 sessions/day). Treatment need not be consecutive; rather, they can be spread across approximately 10 days (eg, Monday, Wednesday, Thursday, Monday, Tuesday, and Wednesday). Participants randomized to active rTMS will receive stimulation applied to the left dorsolateral prefrontal cortex at 110% the resting motor threshold, a 15-Hz rate, 5 seconds per train of pulses, a 10-second intertrial interval, and 40 trains of pulses per session. Each patient will receive approximately 3000 pulses per session. Sham stimulation will be administered at the same parameters as real rTMS; however, no magnetic field will be produced on the placebo side of the active or placebo coil. This protocol was approved by the Edward Hines Jr Veterans Administration Hospital and Jesse Brown Department of Veterans Affairs Medical Center institutional review boards. This study includes a Food and Drug Administration investigational device exemption (G190076). Results: Safety will be assessed using the number of research-related adverse events experienced by the active rTMS group compared to the sham rTMS group. Feasibility will be assessed using protocol completion rates. To examine preliminary effects of rTMS, participants will complete a standardized neurocognitive battery assessment at baseline, end point, and 1-month follow-up. The primary study outcome is the change in score from baseline to end point on the National Institutes of Health–sponsored Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research Executive Composite score. This project was funded in June 2019, with additional funding secured in April 2024. As of April 2025, a total of 18 veterans with PD-MCI have completed the randomized controlled trial phase. Data collection is ongoing and will be completed by March 2027. We expect the results of this study to be available by March 2028. Conclusions: The knowledge gained on the safety, feasibility, and efficacy of rTMS will set the stage for future research optimizing therapeutic gains for existing cognitive rehabilitation treatments or developing new and adjunct treatments for PD-MCI. Trial Registration: ClinicalTrials.gov NCT03836950; https://clinicaltrials.gov/study/NCT03836950 International Registered Report Identifier (IRRID): DERR1-10.2196/77241
- 29 June 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e77241
Open AccessRepetitive Transcranial Magnetic Stimulation as a Cognitive Rehabilitation Approach for Veterans With Parkinson Disease and Mild Cognitive Impairment: Protocol for a Randomized Sham-Controlled Trial
Background: Parkinson disease (PD) is characterized by motor symptoms as well as progressive cognitive decline leading to long-term functional impairment and diminished quality of life. Mild cognitive impairment in PD (PD-MCI) is a risk factor for developing PD-related dementia. PD-MCI provides a window to assess interventions that can improve cognition. Repetitive transcranial magnetic stimulation (rTMS) shows promise as an effective treatment to improve cognitive performance. Objective: This study aims to test the safety and feasibility of a 10-session, high-frequency rTMS protocol applied to the left dorsolateral prefrontal cortex and the rTMS efficacy in improving cognitive test performance among veterans with PD-MCI. Methods: This is a double-blind randomized controlled trial. We will enroll US military veterans with PD-MCI. Participants will be randomized to either active or sham rTMS treatment groups, each with 10 treatment sessions (2 sessions/day). Treatment need not be consecutive; rather, they can be spread across approximately 10 days (eg, Monday, Wednesday, Thursday, Monday, Tuesday, and Wednesday). Participants randomized to active rTMS will receive stimulation applied to the left dorsolateral prefrontal cortex at 110% the resting motor threshold, a 15-Hz rate, 5 seconds per train of pulses, a 10-second intertrial interval, and 40 trains of pulses per session. Each patient will receive approximately 3000 pulses per session. Sham stimulation will be administered at the same parameters as real rTMS; however, no magnetic field will be produced on the placebo side of the active or placebo coil. This protocol was approved by the Edward Hines Jr Veterans Administration Hospital and Jesse Brown Department of Veterans Affairs Medical Center institutional review boards. This study includes a Food and Drug Administration investigational device exemption (G190076). Results: Safety will be assessed using the number of research-related adverse events experienced by the active rTMS group compared to the sham rTMS group. Feasibility will be assessed using protocol completion rates. To examine preliminary effects of rTMS, participants will complete a standardized neurocognitive battery assessment at baseline, end point, and 1-month follow-up. The primary study outcome is the change in score from baseline to end point on the National Institutes of Health–sponsored Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research Executive Composite score. This project was funded in June 2019, with additional funding secured in April 2024. As of April 2025, a total of 18 veterans with PD-MCI have completed the randomized controlled trial phase. Data collection is ongoing and will be completed by March 2027. We expect the results of this study to be available by March 2028. Conclusions: The knowledge gained on the safety, feasibility, and efficacy of rTMS will set the stage for future research optimizing therapeutic gains for existing cognitive rehabilitation treatments or developing new and adjunct treatments for PD-MCI. Trial Registration: ClinicalTrials.gov NCT03836950; https://clinicaltrials.gov/study/NCT03836950 International Registered Report Identifier (IRRID): DERR1-10.2196/77241
- Open Access
- 23 February 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 41 (10) , 1087-1095
Mortality following atypical femoral fractures in men
Atypical femoral fractures (AFFs) are an uncommon complication of bisphosphonate (BP) treatment for osteoporosis. The purpose of this report was to determine differences in mortality among men treated with BPs who experienced AFFs, hip fractures, or typical subtrochanteric/femoral shaft (ST/FS) fractures. We included men from the Veterans Affairs Corporate Data Warehouse who filled at least one BP prescription over a nearly 20-yr span (October 1, 1999, to December 31, 2022). Typical ST/FS and hip fractures after a first filled prescription for a BP were identified using ICD codes. Radiographic review was conducted for ST/FS fractures to determine which were AFFs using the American Society of Bone and Mineral Research 2014 criterion. Demographic and clinical characteristics and cumulative duration of BP exposure prior to the incident fracture were determined. There were 23 men with an AFF, 4591 with a hip fracture, and 225 with a (non-AFF) ST/FS fracture. At 12-mo post-fracture, 4% of men with an AFF had died, compared with 25% of men with a hip fracture and 15% of men with an ST/FS fracture. Over 5 yrs. of follow-up, mortality following fracture differed among the 3 different fracture groups (χ2 = 6.21, d.f. = 2, p = .045) with death occurring in 7 of 23 (30%) men with an AFF, 2380 of 4591 (52%) men with a hip fracture and 109 of 225 (48%) men with a ST/FS fracture. In Cox proportional hazard models, over 5 yrs, with and without adjustment for covariates, there were no significant differences in mortality following an AFF compared with a hip fracture or an AFF compared with a ST/FS fracture (p > .10 for all). It is possible that mortality is lower following AFF compared with a hip or ST/FS fracture; however, limited sample size among those with AFF may have precluded ascertainment of such a difference.
- 23 February 2026
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 41 (10) , 1087-1095
Open AccessMortality following atypical femoral fractures in men
Atypical femoral fractures (AFFs) are an uncommon complication of bisphosphonate (BP) treatment for osteoporosis. The purpose of this report was to determine differences in mortality among men treated with BPs who experienced AFFs, hip fractures, or typical subtrochanteric/femoral shaft (ST/FS) fractures. We included men from the Veterans Affairs Corporate Data Warehouse who filled at least one BP prescription over a nearly 20-yr span (October 1, 1999, to December 31, 2022). Typical ST/FS and hip fractures after a first filled prescription for a BP were identified using ICD codes. Radiographic review was conducted for ST/FS fractures to determine which were AFFs using the American Society of Bone and Mineral Research 2014 criterion. Demographic and clinical characteristics and cumulative duration of BP exposure prior to the incident fracture were determined. There were 23 men with an AFF, 4591 with a hip fracture, and 225 with a (non-AFF) ST/FS fracture. At 12-mo post-fracture, 4% of men with an AFF had died, compared with 25% of men with a hip fracture and 15% of men with an ST/FS fracture. Over 5 yrs. of follow-up, mortality following fracture differed among the 3 different fracture groups (χ2 = 6.21, d.f. = 2, p = .045) with death occurring in 7 of 23 (30%) men with an AFF, 2380 of 4591 (52%) men with a hip fracture and 109 of 225 (48%) men with a ST/FS fracture. In Cox proportional hazard models, over 5 yrs, with and without adjustment for covariates, there were no significant differences in mortality following an AFF compared with a hip fracture or an AFF compared with a ST/FS fracture (p > .10 for all). It is possible that mortality is lower following AFF compared with a hip or ST/FS fracture; however, limited sample size among those with AFF may have precluded ascertainment of such a difference.
- 18 February 2026
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (3) , 509-515
Experiences and Quality of Life Impacts Related to Urinary Tract Infections in Veterans With Neurogenic Bladder: A Mixed Methods Study
Aims: Urinary tract infections (UTIs) are common long‐term complications in people with neurogenic bladder (NB). However, there are limited data on how UTIs impact different aspects of quality of life (QoL) in people with NB. Our objective was to understand UTI‐related QoL impacts in Veterans with NB. Methods: Twenty‐three Veterans with NB and UTI diagnoses in the prior year participated in focus groups to share their perceptions of and experiences with UTIs including QoL impacts. Transcripts were coded using inductive and deductive reasoning. A patient survey was also developed using items modified from existing surveys validated for people with NB and new items generated by the study team using the focus group data. Qualitative results on QoL impacts from focus groups were integrated with the quantitative survey data to provide a more comprehensive understanding of UTI‐related QoL impacts in people with NB. Results: UTIs most significantly impacted daily activities, primarily by impairing mobility and restricting independence which led to more limited participation in social, family, and leisure activities. Psychological impacts were more prominent in the focus groups than the survey data. Conclusions: Results suggest that people with NB may experience substantial QoL impacts from UTIs, and patient‐centered interventions may be needed to decrease the impact of UTIs.
- 18 February 2026
- Published by Wiley in Neurourology and Urodynamics
- Vol. 45 (3) , 509-515
Experiences and Quality of Life Impacts Related to Urinary Tract Infections in Veterans With Neurogenic Bladder: A Mixed Methods Study
Aims: Urinary tract infections (UTIs) are common long‐term complications in people with neurogenic bladder (NB). However, there are limited data on how UTIs impact different aspects of quality of life (QoL) in people with NB. Our objective was to understand UTI‐related QoL impacts in Veterans with NB. Methods: Twenty‐three Veterans with NB and UTI diagnoses in the prior year participated in focus groups to share their perceptions of and experiences with UTIs including QoL impacts. Transcripts were coded using inductive and deductive reasoning. A patient survey was also developed using items modified from existing surveys validated for people with NB and new items generated by the study team using the focus group data. Qualitative results on QoL impacts from focus groups were integrated with the quantitative survey data to provide a more comprehensive understanding of UTI‐related QoL impacts in people with NB. Results: UTIs most significantly impacted daily activities, primarily by impairing mobility and restricting independence which led to more limited participation in social, family, and leisure activities. Psychological impacts were more prominent in the focus groups than the survey data. Conclusions: Results suggest that people with NB may experience substantial QoL impacts from UTIs, and patient‐centered interventions may be needed to decrease the impact of UTIs.
- 12 December 2025
- Published by Wolters Kluwer Health in Medical Care
- Vol. 64 (2S) , S119-S123
Veterans’ Experiences With Legislation to Address Health Care and Disability Related to Contaminated Water Exposure at Camp Lejeune Marine Base
Background: Between 1953 and 1987, the groundwater at Marine Base Camp Lejeune in North Carolina was contaminated with chlorinated solvents. Legislation enacted by the federal government aimed to provide disability compensation and access to health care to Veterans for conditions related to these exposures. Objective: We assessed the impact of the Camp Lejeune-related legislation on Veterans’ experiences with health care access and disability claims. Measure: A total of 8864 Veterans who were at Camp Lejeune between 1975 and 1985 were invited to complete an online survey about their experiences with health care and seeking compensation for conditions associated with toxicant exposure. Results: Approximately 964 surveys (13%) were fully completed and analyzed. One-third of respondents reported a diagnosis of at least one associated or presumptive condition linked to toxicant exposure. Veterans who reported living/working in higher risk areas at the Camp had a 2.02 [CI: 1.41, 2.90] greater odds of being diagnosed with one of these conditions, controlling for demographic characteristics. While most Veterans accessed and were satisfied with Veterans Health Administration (VA) care, those who applied for disability compensation found the process to be unhelpful. Conclusion: Conditions associated with or presumptive for toxicant exposures at Camp Lejeune were frequently identified by respondents. Veterans who lived/worked in a high-risk area of the camp were twice as likely to have any of these conditions. There is a need for additional education of Veterans regarding the Camp Lejeune legislation, particularly around the disability claims filing process, and the increased risk of those who lived near the contaminated wells at Camp Lejeune.
- 12 December 2025
- Published by Wolters Kluwer Health in Medical Care
- Vol. 64 (2S) , S119-S123
Veterans’ Experiences With Legislation to Address Health Care and Disability Related to Contaminated Water Exposure at Camp Lejeune Marine Base
Background: Between 1953 and 1987, the groundwater at Marine Base Camp Lejeune in North Carolina was contaminated with chlorinated solvents. Legislation enacted by the federal government aimed to provide disability compensation and access to health care to Veterans for conditions related to these exposures. Objective: We assessed the impact of the Camp Lejeune-related legislation on Veterans’ experiences with health care access and disability claims. Measure: A total of 8864 Veterans who were at Camp Lejeune between 1975 and 1985 were invited to complete an online survey about their experiences with health care and seeking compensation for conditions associated with toxicant exposure. Results: Approximately 964 surveys (13%) were fully completed and analyzed. One-third of respondents reported a diagnosis of at least one associated or presumptive condition linked to toxicant exposure. Veterans who reported living/working in higher risk areas at the Camp had a 2.02 [CI: 1.41, 2.90] greater odds of being diagnosed with one of these conditions, controlling for demographic characteristics. While most Veterans accessed and were satisfied with Veterans Health Administration (VA) care, those who applied for disability compensation found the process to be unhelpful. Conclusion: Conditions associated with or presumptive for toxicant exposures at Camp Lejeune were frequently identified by respondents. Veterans who lived/worked in a high-risk area of the camp were twice as likely to have any of these conditions. There is a need for additional education of Veterans regarding the Camp Lejeune legislation, particularly around the disability claims filing process, and the increased risk of those who lived near the contaminated wells at Camp Lejeune.
- 15 September 2025
- Published by Wolters Kluwer Health in Medical Care
- Vol. 64 (1S) , S73-S81
Feasibility, Usability, and Satisfaction of a Decision Support Tool to Prevent Community-Acquired Pressure Injuries for Use in the Spinal Cord Injury Clinic
Background: Community-acquired pressure injuries (CAPrIs) are common and costly among individuals living with spinal cord injury (SCI). Objectives: Describe feasibility, usability, and satisfaction of a decision support tool to prevent CAPrIs in individuals with SCI and effect of the Community-Acquired Pressure Injury Prevention-Field Implementation Tool (CAPP-FIT) on CAPrI incidence 6 months post CAPP-FIT implementation. Methods: Preparation for the pilot included redesigning clinic workflow and training providers using a simulation with a standardized patient. The CAPP-FIT was piloted with community-dwelling veterans with scheduled in-person and telehealth clinic visits. Processes were assessed using contextual inquiry and monthly provider meetings. Feasibility, usability, and satisfaction were assessed using the mobile application rating scale with veterans and focus groups with providers. CAPrI incidence 6 months post CAPP-FIT intervention was assessed using a propensity match of veterans who did not receive the CAPP-FIT intervention. A modified Poisson regression with difference in differences was used to estimate the incidence rate ratio of CAPrIs. Results: Participants included 7 providers (3 registered nurses, 2 nurse practitioners, 2 physicians). Veteran participants (n=103) had a mean age of 64; 50% White, 33% Black; 56% with paraplegia; and 72% with incomplete injury. Veteran participants were satisfied with the CAPP-FIT, agreed questions were relevant, and improved their conversations with providers. Providers felt the CAPP-FIT was easy to use, improved communications, and promoted preventive care. Participants experienced a lower CAPrI incidence rate compared with a propensity-matched sample at the pilot site, with the decrease among CAPP FIT participants being more pronounced than among non-participants. However, the difference in difference was not statistically significant with IRR: 0.23, 95% CI: 0.048–1.066 ( P =0.060). Conclusions: The CAPP-FIT seems to be a useful tool in the SCI Clinic to prevent CAPrIs in veterans with SCI, but further testing is warranted.
- 15 September 2025
- Published by Wolters Kluwer Health in Medical Care
- Vol. 64 (1S) , S73-S81
Feasibility, Usability, and Satisfaction of a Decision Support Tool to Prevent Community-Acquired Pressure Injuries for Use in the Spinal Cord Injury Clinic
Background: Community-acquired pressure injuries (CAPrIs) are common and costly among individuals living with spinal cord injury (SCI). Objectives: Describe feasibility, usability, and satisfaction of a decision support tool to prevent CAPrIs in individuals with SCI and effect of the Community-Acquired Pressure Injury Prevention-Field Implementation Tool (CAPP-FIT) on CAPrI incidence 6 months post CAPP-FIT implementation. Methods: Preparation for the pilot included redesigning clinic workflow and training providers using a simulation with a standardized patient. The CAPP-FIT was piloted with community-dwelling veterans with scheduled in-person and telehealth clinic visits. Processes were assessed using contextual inquiry and monthly provider meetings. Feasibility, usability, and satisfaction were assessed using the mobile application rating scale with veterans and focus groups with providers. CAPrI incidence 6 months post CAPP-FIT intervention was assessed using a propensity match of veterans who did not receive the CAPP-FIT intervention. A modified Poisson regression with difference in differences was used to estimate the incidence rate ratio of CAPrIs. Results: Participants included 7 providers (3 registered nurses, 2 nurse practitioners, 2 physicians). Veteran participants (n=103) had a mean age of 64; 50% White, 33% Black; 56% with paraplegia; and 72% with incomplete injury. Veteran participants were satisfied with the CAPP-FIT, agreed questions were relevant, and improved their conversations with providers. Providers felt the CAPP-FIT was easy to use, improved communications, and promoted preventive care. Participants experienced a lower CAPrI incidence rate compared with a propensity-matched sample at the pilot site, with the decrease among CAPP FIT participants being more pronounced than among non-participants. However, the difference in difference was not statistically significant with IRR: 0.23, 95% CI: 0.048–1.066 ( P =0.060). Conclusions: The CAPP-FIT seems to be a useful tool in the SCI Clinic to prevent CAPrIs in veterans with SCI, but further testing is warranted.
- Open Access
- 9 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Repetitive Transcranial Magnetic Stimulation as a Cognitive Rehabilitation Approach for Veterans With Parkinson Disease and Mild Cognitive Impairment: Protocol for a Randomized Sham-Controlled Trial (Preprint)
BACKGROUND Parkinson disease (PD) is characterized by motor symptoms as well as progressive cognitive decline leading to long-term functional impairment and diminished quality of life. Mild cognitive impairment in PD (PD-MCI) is a risk factor for developing PD-related dementia. PD-MCI provides a window to assess interventions that can improve cognition. Repetitive transcranial magnetic stimulation (rTMS) shows promise as an effective treatment to improve cognitive performance. OBJECTIVE This study aims to test the safety and feasibility of a 10-session, high-frequency rTMS protocol applied to the left dorsolateral prefrontal cortex and the rTMS efficacy in improving cognitive test performance among veterans with PD-MCI. METHODS This is a double-blind randomized controlled trial. We will enroll US military veterans with PD-MCI. Participants will be randomized to either active or sham rTMS treatment groups, each with 10 treatment sessions (2 sessions/day). Treatment need not be consecutive; rather, they can be spread across approximately 10 days (eg, Monday, Wednesday, Thursday, Monday, Tuesday, and Wednesday). Participants randomized to active rTMS will receive stimulation applied to the left dorsolateral prefrontal cortex at 110% the resting motor threshold, a 15-Hz rate, 5 seconds per train of pulses, a 10-second intertrial interval, and 40 trains of pulses per session. Each patient will receive approximately 3000 pulses per session. Sham stimulation will be administered at the same parameters as real rTMS; however, no magnetic field will be produced on the placebo side of the active or placebo coil. This protocol was approved by the Edward Hines Jr Veterans Administration Hospital and Jesse Brown Department of Veterans Affairs Medical Center institutional review boards. This study includes a Food and Drug Administration investigational device exemption (G190076). RESULTS Safety will be assessed using the number of research-related adverse events experienced by the active rTMS group compared to the sham rTMS group. Feasibility will be assessed using protocol completion rates. To examine preliminary effects of rTMS, participants will complete a standardized neurocognitive battery assessment at baseline, end point, and 1-month follow-up. The primary study outcome is the change in score from baseline to end point on the National Institutes of Health–sponsored Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research Executive Composite score. This project was funded in June 2019, with additional funding secured in April 2024. As of April 2025, a total of 18 veterans with PD-MCI have completed the randomized controlled trial phase. Data collection is ongoing and will be completed by March 2027. We expect the results of this study to be available by March 2028. CONCLUSIONS The knowledge gained on the safety, feasibility, and efficacy of rTMS will set the stage for future research optimizing therapeutic gains for existing cognitive rehabilitation treatments or developing new and adjunct treatments for PD-MCI. CLINICALTRIAL ClinicalTrials.gov NCT03836950; https://clinicaltrials.gov/study/NCT03836950 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/77241
- 9 September 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessRepetitive Transcranial Magnetic Stimulation as a Cognitive Rehabilitation Approach for Veterans With Parkinson Disease and Mild Cognitive Impairment: Protocol for a Randomized Sham-Controlled Trial (Preprint)
BACKGROUND Parkinson disease (PD) is characterized by motor symptoms as well as progressive cognitive decline leading to long-term functional impairment and diminished quality of life. Mild cognitive impairment in PD (PD-MCI) is a risk factor for developing PD-related dementia. PD-MCI provides a window to assess interventions that can improve cognition. Repetitive transcranial magnetic stimulation (rTMS) shows promise as an effective treatment to improve cognitive performance. OBJECTIVE This study aims to test the safety and feasibility of a 10-session, high-frequency rTMS protocol applied to the left dorsolateral prefrontal cortex and the rTMS efficacy in improving cognitive test performance among veterans with PD-MCI. METHODS This is a double-blind randomized controlled trial. We will enroll US military veterans with PD-MCI. Participants will be randomized to either active or sham rTMS treatment groups, each with 10 treatment sessions (2 sessions/day). Treatment need not be consecutive; rather, they can be spread across approximately 10 days (eg, Monday, Wednesday, Thursday, Monday, Tuesday, and Wednesday). Participants randomized to active rTMS will receive stimulation applied to the left dorsolateral prefrontal cortex at 110% the resting motor threshold, a 15-Hz rate, 5 seconds per train of pulses, a 10-second intertrial interval, and 40 trains of pulses per session. Each patient will receive approximately 3000 pulses per session. Sham stimulation will be administered at the same parameters as real rTMS; however, no magnetic field will be produced on the placebo side of the active or placebo coil. This protocol was approved by the Edward Hines Jr Veterans Administration Hospital and Jesse Brown Department of Veterans Affairs Medical Center institutional review boards. This study includes a Food and Drug Administration investigational device exemption (G190076). RESULTS Safety will be assessed using the number of research-related adverse events experienced by the active rTMS group compared to the sham rTMS group. Feasibility will be assessed using protocol completion rates. To examine preliminary effects of rTMS, participants will complete a standardized neurocognitive battery assessment at baseline, end point, and 1-month follow-up. The primary study outcome is the change in score from baseline to end point on the National Institutes of Health–sponsored Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research Executive Composite score. This project was funded in June 2019, with additional funding secured in April 2024. As of April 2025, a total of 18 veterans with PD-MCI have completed the randomized controlled trial phase. Data collection is ongoing and will be completed by March 2027. We expect the results of this study to be available by March 2028. CONCLUSIONS The knowledge gained on the safety, feasibility, and efficacy of rTMS will set the stage for future research optimizing therapeutic gains for existing cognitive rehabilitation treatments or developing new and adjunct treatments for PD-MCI. CLINICALTRIAL ClinicalTrials.gov NCT03836950; https://clinicaltrials.gov/study/NCT03836950 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/77241
- 22 April 2025
- Published by Springer Nature in Spinal Cord Series and Cases
- Vol. 11 (1) , 1-8
A root cause analysis of community-acquired pressure injuries in persons with spinal cord injuries
Study Design Multi-phase root cause analysis (RCA) Objectives Determine the root cause of why veterans developed a novel CAPrI following the completion of the CAPP-FIT intervention from the providers and veterans’ perspectives. Setting A Midwest Veteran Health Administration (VHA) facility SCI clinic. Methods RCA using Five Why’s method and chronology mapping for veterans with spinal cord injury who developed a novel community-acquired pressure injury (CAPrI) following use of a decision support tool to prevent CAPrIs, called the Community Acquired Pressure Injury Prevention—Field Implementation Tool (CAPP-FIT). Data sources include the electronic health record and veteran responses to the CAPP-FIT. Results Key themes emerged describing differing provider/veteran perspectives and barriers that led to the development of a novel CAPrI. Themes included (1) disagreement in level of care needed due to complexity of needs or differing priorities; (2) focus on education and treatment over prevention; (3) barriers in accessing VHA care; and (4) veteran and informal resource engagement. Conclusion CAPrI’s develop quickly, and some can be prevented. Improving the speed that veterans gain access to critical services (e.g., caregiver and specialists), as well as improving communication at the system level (i.e., across VHA facilities and to private facilities) can decrease the risk of CAPrI’s.
- 22 April 2025
- Published by Springer Nature in Spinal Cord Series and Cases
- Vol. 11 (1) , 1-8
A root cause analysis of community-acquired pressure injuries in persons with spinal cord injuries
Study Design Multi-phase root cause analysis (RCA) Objectives Determine the root cause of why veterans developed a novel CAPrI following the completion of the CAPP-FIT intervention from the providers and veterans’ perspectives. Setting A Midwest Veteran Health Administration (VHA) facility SCI clinic. Methods RCA using Five Why’s method and chronology mapping for veterans with spinal cord injury who developed a novel community-acquired pressure injury (CAPrI) following use of a decision support tool to prevent CAPrIs, called the Community Acquired Pressure Injury Prevention—Field Implementation Tool (CAPP-FIT). Data sources include the electronic health record and veteran responses to the CAPP-FIT. Results Key themes emerged describing differing provider/veteran perspectives and barriers that led to the development of a novel CAPrI. Themes included (1) disagreement in level of care needed due to complexity of needs or differing priorities; (2) focus on education and treatment over prevention; (3) barriers in accessing VHA care; and (4) veteran and informal resource engagement. Conclusion CAPrI’s develop quickly, and some can be prevented. Improving the speed that veterans gain access to critical services (e.g., caregiver and specialists), as well as improving communication at the system level (i.e., across VHA facilities and to private facilities) can decrease the risk of CAPrI’s.
- 10 March 2025
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 40 (8) , 1888-1899
Barriers and Facilitators to Cross-Institutional Referrals: System Configuration Analysis of VA Staff Experiences
Background In 2014 and 2018, respectively, Congress passed the Veterans Access, Choice, and Accountability Act (Choice Act) and the Maintaining Internal Systems and Strengthening Integrated Outside Networks Act (MISSION Act), which expanded eligibility for and use of cross-institutional referrals among U.S. Veterans enrolled in the Veterans Health Administration. Objective To identify facilitators and barriers to patient information sharing for cross-institutional, outpatient referrals resulting from policy changes. Design Applying the Systems Engineering Initiative for Patient Safety (SEIPS) 2.0 framework, we conducted work system and configural analyses of semi-structured interviews. Participants Clinical and administrative staff in six Department of Veterans Affairs (VA) facility community care liaison program offices. Approach Interviews focused on barriers and facilitators to sharing patients’ information across healthcare institutions. Transcripts were summarized by domain and coded to consensus, followed by directed content analysis and visualization using configural diagrams. Key Results From 19 interviews, we characterized a nine-step, ad hoc referral process. Barriers were reported in four of nine referral steps: scheduling, coordination, sending of pre-visit clinical records, and receipt of post-visit records. Low adoption of new technology, strained relationships with CCN clinicians, and inconsistent policies were commonly reported barriers. Largely, perceived barriers were classified as technology, people, or organization factors. The COVID-19 pandemic and a transition between third-party administrators were reported as notable environment factors. Conclusions VA staff perceived increases in patient care delays and staff workload associated with social and technical barriers to sharing patients’ information across healthcare institutions. In the cross-institutional referral process, we identified the primary configuration or combination of work system factors—technology, people, and organization— related to prevalent barriers. System-level interventions are needed to enhance relationships with clinicians across healthcare institutions, implement policies that guide patient information exchange, and design supportive technologies for efficient clinician communication during cross-institutional referrals.
- 10 March 2025
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 40 (8) , 1888-1899
Barriers and Facilitators to Cross-Institutional Referrals: System Configuration Analysis of VA Staff Experiences
Background In 2014 and 2018, respectively, Congress passed the Veterans Access, Choice, and Accountability Act (Choice Act) and the Maintaining Internal Systems and Strengthening Integrated Outside Networks Act (MISSION Act), which expanded eligibility for and use of cross-institutional referrals among U.S. Veterans enrolled in the Veterans Health Administration. Objective To identify facilitators and barriers to patient information sharing for cross-institutional, outpatient referrals resulting from policy changes. Design Applying the Systems Engineering Initiative for Patient Safety (SEIPS) 2.0 framework, we conducted work system and configural analyses of semi-structured interviews. Participants Clinical and administrative staff in six Department of Veterans Affairs (VA) facility community care liaison program offices. Approach Interviews focused on barriers and facilitators to sharing patients’ information across healthcare institutions. Transcripts were summarized by domain and coded to consensus, followed by directed content analysis and visualization using configural diagrams. Key Results From 19 interviews, we characterized a nine-step, ad hoc referral process. Barriers were reported in four of nine referral steps: scheduling, coordination, sending of pre-visit clinical records, and receipt of post-visit records. Low adoption of new technology, strained relationships with CCN clinicians, and inconsistent policies were commonly reported barriers. Largely, perceived barriers were classified as technology, people, or organization factors. The COVID-19 pandemic and a transition between third-party administrators were reported as notable environment factors. Conclusions VA staff perceived increases in patient care delays and staff workload associated with social and technical barriers to sharing patients’ information across healthcare institutions. In the cross-institutional referral process, we identified the primary configuration or combination of work system factors—technology, people, and organization— related to prevalent barriers. System-level interventions are needed to enhance relationships with clinicians across healthcare institutions, implement policies that guide patient information exchange, and design supportive technologies for efficient clinician communication during cross-institutional referrals.
- Open Access
- 20 August 2024
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 14 (6) , 1265-1269
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort
Post-traumatic stress disorder (PTSD) may be a risk factor for Parkinson’s disease (PD). We examined the relation between PTSD and PD in a cohort of 158,122 Veterans who had any Veterans Health Administration (VHA) or Medicare health care utilization between 10/1/1999– 2/17/2021. Using a nested case-control design we matched 10 controls to each Veteran with PD by sex, race, and rank. In conditional logistic regression models adjusted for camp and smoking, a PTSD diagnosis was significantly associated with PD (OR = 1.35; p = 0.0002); odds were higher if PTSD was coded before PD (OR = 1.53, p < 0.0001). PTSD may be a risk factor for PD.
- 20 August 2024
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 14 (6) , 1265-1269
Open AccessPost-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort
Post-traumatic stress disorder (PTSD) may be a risk factor for Parkinson’s disease (PD). We examined the relation between PTSD and PD in a cohort of 158,122 Veterans who had any Veterans Health Administration (VHA) or Medicare health care utilization between 10/1/1999– 2/17/2021. Using a nested case-control design we matched 10 controls to each Veteran with PD by sex, race, and rank. In conditional logistic regression models adjusted for camp and smoking, a PTSD diagnosis was significantly associated with PD (OR = 1.35; p = 0.0002); odds were higher if PTSD was coded before PD (OR = 1.53, p < 0.0001). PTSD may be a risk factor for PD.